Increased Risk of Complications in Total Hip Arthroplasty (THA) of Femoral Neck Fracture (FNF): A Comparative Meta-Analysis of THA Outcomes in FNF and Osteoarthritis

股骨颈骨折(FNF)患者行全髋关节置换术(THA)并发症风险增加:FNF和骨关节炎患者THA疗效的比较荟萃分析

阅读:1

Abstract

Despite contradictory results of various published data on the subject, the complications of total hip arthroplasty (THA) in femoral neck fracture (FNF) compared to those in osteoarthritis (OA) are yet to be further elucidated. We queried PubMed, Cochrane, and Google Scholar from inception until October 2024 for studies that compared the surgical outcomes of THA in the management of FNF and OA. We evaluated the overall complications, such as dislocations, prosthetic joint infection (PJI), intraoperative fractures, periprosthetic fractures (PPFx), mechanical loosening, venous thromboembolism (VTE), hematoma, leg length discrepancy (LLD), and revisions. In addition, surgical parameters such as the duration of surgery and the length of stay (LOS) were also assessed. Eleven studies were included in our meta-analysis. The use of THA in FNF is associated with high risks of overall complications (odds ratio [OR] 1.58, 95% confidence interval [CI] 1.00-2.49, P=0.05), dislocations (OR 2.12, 95% CI 1.07-4.21, P=0.03), PJI (OR 1.75, 95% CI 1.50-2.05, P<0.00001), PPFx (OR 1.62, 95% CI 1.18-2.22, P=0.003), and intraoperative fractures (OR 3.82, 95% CI 1.59-9.19, P=0.003) in comparison to those in the OA group treated with THA. FNF patients had a long LOS (mean difference=3.34, 95% CI 0.69-5.99, P=0.01). There was no statistically significant difference observed in the risk of VTE, hematoma, LLD, mechanical loosening, the number of revisions, and the duration of surgery between the FNF and OA groups, which were treated with THA. There is an increased risk of complications in patients undergoing THA for FNF than in patients undergoing THA for OA.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。